Fidelity Blue Chip Growth ETFFBCG
FBCG
0
Funds holding %
of 6,823 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
159% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 27
25% more funds holding in top 10
Funds holding in top 10: 4 [Q2] → 5 (+1) [Q3]
19% more capital invested
Capital invested by funds: $869M [Q2] → $1.04B (+$169M) [Q3]
2.37% more ownership
Funds ownership: 45.93% [Q2] → 48.31% (+2.37%) [Q3]
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
2% less funds holding
Funds holding: 135 [Q2] → 132 (-3) [Q3]
Research analyst outlook
We haven’t received any recent analyst ratings for FBCG.
Financial journalist opinion
Based on 6 articles about FBCG published over the past 30 days
Positive
Seeking Alpha
1 week ago
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
This article will provide an in-depth analysis of drugs being developed to combat cancer. Big Pharma is keenly interested in the global cancer therapeutics market, which is expected to exceed $400 billion by 2028. Every year, the FDA and EMA approve dozens of anticancer drugs, so Seeking Alpha readers should be careful when making decisions.
Neutral
ETF Trends
1 week ago
VIDEO: ETF of the Week: FBCG
On this episode of “ETF of the Week” podcast, VettaFi's Head of Research Todd Rosenbluth joined Chuck Jaffe of Money Life to talk about the Fidelity Blue Chip Growth ETF (FBCG). Chuck Jaffe: One fund, on point for today; the expert to talk about it.
Neutral
ETF Trends
1 week ago
ETF of the Week: Fidelity Blue Chip Growth ETF (FBCG)
VettaFi's Head of Research Todd Rosenbluth discussed the Fidelity Blue Chip Growth ETF (FBCG) on this week's “ETF of the Week” podcast with Chuck Jaffe of “Money Life.” For more news, information, and analysis, visit VettaFi | ETF Trends.
Positive
Zacks Investment Research
2 weeks ago
Equity Dominates ETF Inflows at the Start of 2025
Investors poured in 31.7 billion in capital to start 2025, with U.S. equity ETFs leading the way.
Positive
Zacks Investment Research
2 weeks ago
Blue-Chip ETF (FBCG) Hits New 52-Week High
For investors seeking momentum, Fidelity Blue Chip Growth ETF FBCG is probably on the radar. The fund just hit a 52-week high and has moved up 46.4% from its 52-week low of $32.91 per share.
Positive
ETF Trends
2 weeks ago
3 Top-Performing Fidelity ETFs Offer 2024 Insight
With the end of the year on the horizon, investors often reflect on insights from the market's performance. Three ETFs from Fidelity Investments can offer some notable takeaways as they are likely to end 2024 as the firm's top ETF performers.
Positive
ETF Trends
2 months ago
Under the Hood of Fidelity's Blue Chip Growth ETF
Fidelity Investments' blue chip growth ETF has generated attractive returns for investors. The Fidelity Blue Chip Growth ETF (FBCG) is a U.S. equity growth strategy with a large-cap bias.
Positive
ETF Trends
2 months ago
Under Radar Active Equity ETFs
Actively managed equity ETFs have continued to gain traction in 2024 and risen in value. Some of the top performing funds were focused on in vogue, large-cap growth stocks such as the American Century Focused Dynamic Growth ETF (FDG) and the Fidelity Blue Chip Growth ETF (FBCG).
Neutral
ETF Trends
3 months ago
ETF Prime: Rosenbluth on Semitransparent Active ETFs & More
On this week's episode of ETF Prime, host Nate Geraci sat down with VettaFi's Head of Research Todd Rosenbluth to discuss Bitwise's XRP filing, semitransparent active ETFs, and CLOs. Later, Geraci welcomed Palmer Square founder Chris Long to discuss the $32 billion firm's ETF entrance.
Positive
Seeking Alpha
3 months ago
FBCG: Growth Is Poised To Outperform Value Ahead
Despite recent rotation to value stocks, growth stocks are expected to lead due to robust earnings forecasts in tech, communication, and consumer cyclical sectors. Initiate coverage of Fidelity Blue Chip Growth ETF with a buy rating due to its strong upside momentum, liquidity, and diversified portfolio. FBCG outperformed peers like SCHG and TCHP, thanks to its extensive diversification and significant exposure to high-growth sectors, ensuring the potential for lofty returns.
Charts implemented using Lightweight Charts™